ArticleNutrition & metabolism2026
Association between monounsaturated fatty acids intake with Parkinson's disease: a cross-sectional study.
Article in Nutrition & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundTo investigate the association between monounsaturated fatty acids (MUFAs) intake and the prevalence of Parkinson’s disease (PD) among US adults using data from the National Health and Nutrition Examination Survey (NHANES) database.
methodsCross-sectional data from the NHANES 2001–2018 were selected. PD cases were identified through self-reported PD medications. MUFAs intake was determined from dietary interview data for two 24-hour periods. To address severe outcome imbalance and improve covariate comparability, we conducted survey-weighted propensity score matching (PSM) incorporating NHANES sampling weights. In the matched sample, survey-weighted logistic regression was used to evaluate the association between MUFAs intake (quartiles) and PD prevalence, and a trend test was performed. Restricted cubic spline (RCS) models were applied to examine potential non-linear associations.
resultsA total of 12,122 participants were included, consisting of 84 PD patients and 12,038 participants without PD. MUFAs intake was significantly lower in the PD group than in matched controls after PSM (P = 0.010). Exploratory subgroup analyses suggested heterogeneity across some subpopulations. RCS analyses did not indicate a significant non-linear relationship between MUFAs intake and the prevalence of PD.
conclusionHigher MUFAs intake was inversely associated with PD prevalence in this cross-sectional analysis. Given the study design, causality cannot be inferred; prospective studies are warranted to confirm these findings and clarify underlying mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.